Saturday 26 November 2016

New Report Highlights Growing UK Support for Medical Cannabis

Politics  The latest in cannabis legalization including laws and policies, legislators’ views, election coverage, and more.

New Report Highlights Growing UK Support for Medical Cannabis

Sean Carney
November 26, 2016

LONDON — The United Kingdom, long home to anti-drug crusaders, is turning a corner on cannabis. Politicians and members of the public increasingly agree on the need to allow and smartly regulate medical cannabis, creating potential not only for reform but for the launch of a legal marketplace.

This week, the London-based free market-oriented think tank Adam Smith Institute (ASI)—where staff look more like Tory conservatives than herbal enthusiasts—released a report in coordination with English drug-policy think tank VolteFace that concludes the regulation of cannabis is “substantially more desirable than simple decriminalization or unregulated legalization.”

“Only regulation,” the report says, “addresses all four key issues: ensuring that the product meets acceptable standards of quality and purity; removing criminal gangs from the equation as far as possible; raising revenue for the Treasury through point-of-sale taxation; and best protecting public health.”

English authorities have long argued that cannabis has no medical value and merely exacerbates society’s problems, with cannabis-induced psychosis being the fear-mongering threat of choice among critics. But things are changing fast. In October the country’s health service announced that cannabidiol (CBD), a non-psychoactive compound in cannabis, indeed holds medical value and should be regulated similarly to other medicines.

RELATED STORY
CBD vs. THC: Why is CBD Not Psychoactive?

The ASI report follows a UK parliamentary report from September that supported medical cannabis regulation, and it and comes the same week as the Global Commission on Drugs called for decriminalization of all drugs worldwide.

Experts agreed with the ASI report’s conclusion that prohibition in England is only hurting society and that it’s time for change to a fact-based, harm-reduction approach. “I very, very much welcome this report,” Paul Hayes, a drug-policy professor and former CEO of the National Treatment Agency for Substance Misuse, said Monday at a public debate hosted by VolteFace.

The report’s findings include a recommendation that language around drugs—and cannabis in particular—needs to be amended so politicians and voters don’t get stuck in outdated paradigms. It notes that current regulations hamstring research into the benefits and harms of cannabis, adding that consumption should become a health department issue, not a criminal justice matter.

RELATED STORY
This One Chart Captures Everything Wrong with NYC Cannabis Arrests

Both conservatives and liberals at the debate agreed on the need to put people first. How to accomplish that, however, is less clear.

The financial implications of cannabis legalization are a particular sticking point. A key finding of the report is that the UK cannabis market amounts to roughly £7 billion ($8.7 billion) annually—which could generate up to £1 billion a year in tax revenue.

Hayes, at the VolteFace debate, argued that he’s concerned that free market operators would be driven more by profit than public health. On top of that, he warned, cannabis marketing could have a negative impact on mental health.

“I would ask you to remember the people” who are at risk when drafting position papers on legalization, Hayes said at the debate to Sam Bowman, ASI’s deputy director.

Bowman replied that what currently exists in the UK “is the worst of all possible worlds,” suggesting that current British drug policy actually perpetuates crime, allows children relatively easy access to cannabis, and ignores the reality that cannabis does not kill even as hundreds of thousands die of problems related to alcohol, tobacco, and even refined sugar.

RELATED STORY
Here’s Why Cannabis Legalization Doesn’t Lead to Higher Teen Use Rates

“If you care about young people, then legalize it and regulate it,” Bowman told Hayes, calling also for the expungement of criminal records for people convicted of nonviolent drug crimes.

The growing agreement in England that some form of legalization and smart regulation is needed comes on the coattails of recent developments in Ireland, where the Parliament on Dec. 1 is set to take up debate on a medical cannabis legalization bill.

Boris Starling, an English journalist who authored the ASI report, said that an honest debate on cannabis policy is “no longer an outlier. It’s happening around the world. We’re going to be left behind if we don’t do something.”

Sean Carney
Sean Carney is Leafly’s Europe editor. In the 10 years prior to joining Leafly, he was a reporter for The Wall Street Journal, where he initiated coverage of central European drug policy and of the cannabis industry.
Recent Articles
Central European Legalization Efforts Gaining Political Support
Exclusive: Seattle Officials Crafting Bill to Legalize Cannabis Delivery in Washington
Montana Patients Seek Immediate Re-Opening of Medical Dispensaries
Cannabis Farms On the New Jersey Turnpike? Maybe Sooner Than You Think.

The post New Report Highlights Growing UK Support for Medical Cannabis appeared first on Leafly.



from
https://www.leafly.com/news/politics/new-report-highlights-growing-uk-support-medical-cannabis

1 comment:

  1. Buy Medical Marijuana Online in USA
    Khali Plug 420 is an Online Medical Marijuana Dispensary with Organically grown Marijuana Strains. We are Safe, Reliable, and legal offering discrete mail order delivery to US, UK, Australia and Europe. Visit us at www.khaliplug420.com and browse a variety of our Premium quality Medical Marijuana Strains. We offer OG Kush, Master Kush, High Grade and Medium Grade Marijuana, White widow, AK47, Moonrock, Gelato, Pre rolled joints of indica etc and sativa strains, edibles, Marijuana Cookies and Crispies and Marijuana seeds of all kinds. Khali Plug 420 is your One stop shop for Organic Sativa, Indica and Hybrid with 28+ Cannabis Strains, Free Shipping worldwide with next day delivery for all Medical Marijuana Strains.
    Cannabis can be classified in many different ways. Typically, this resinous flower is categorized as sativa, hybrid, or indica, based on anticipated effects and/or the morphology of the plant. These terms refer to types of cannabis characterized by distinct smells, flavors, effects, and/or geographic regions.
    What Characterizes ‘Kush’ Cannabis?
    Kush is a particular variety of cannabis that descends from the Hindu Kush Mountains. This mountain range spans the Afghanistan-Pakistan border and is one of the few geographic regions where the cannabis plant grows natively.
    Having strong Kush genetics usually means a strain will have a few of the following attributes:
    Appearance: Your strain may exhibit deep green colas and leaves with hints of purple. Pistils (hairs) can look orange, bronze, or rust colored. Buds are dense, chunky, and knotted, coming from squat, thick plants.
    Smell: Aroma can vary between earthy, floral, pungent, pine, incense, sweet fruit, hash spice, pepper, citrus, gas, and herbs.
    Flavor: Smoke or vapor should be smooth and herbaceous, tasting of flowers, grape, diesel, citrus, and earth.
    Effects: Kush usually vacillates between hybrid and indica dominance. The effects are typically heavy and sedative. OG Kush crosses are usually coupled with a bright euphoria that puts a smile on the couch locked consumer.-
    Keep in mind that these attributes can vary from Kush strain to Kush strain.
    More information:
    Contact Us
    Address:
    Phone: +1 (903) 326-9722
    Email: kushkhali28@gmail.com

    ReplyDelete